RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
ACRO Biomedical Co Stock

ACRO Biomedical Co Debt 2024

ACRO Biomedical Co Debt

0.07 USD

Ticker

ACBM

ISIN

US0048921052

In 2024, ACRO Biomedical Co's total debt was 0.07 USD, a -187.5% change from the -0.08 USD total debt recorded in the previous year.

ACRO Biomedical Co Aktienanalyse

What does ACRO Biomedical Co do?

ACRO Biomedical Co Ltd is a leading company in biomedical technology based in Taipei, Taiwan. The company was established in 2006 and has since successfully established itself in the global market for biomedical products and technologies. The company's vision is to improve people's lives and promote health worldwide through innovative and high-quality products and solutions. Business model: ACRO Biomedical Co Ltd specializes in the development, manufacturing, and marketing of biomedical products and technologies. The company has three main divisions: Regenerative Medicine, Wound Care, and Surgical Technology. Each division focuses on developing products and solutions tailored to the needs of patients and medical professionals. Regenerative Medicine: ACRO Biomedical Co Ltd is a leading provider of regenerative biomedical products. Under this division, the company develops innovative solutions for tissue regeneration, such as bioimplants made from natural tissues and biomaterials to repair or restore damaged tissue. These products are used for the treatment of injuries, chronic diseases, and degenerative conditions. Additionally, ACRO Biomedical Co Ltd has also developed solutions for cosmetic and aesthetic applications. Wound Care: ACRO Biomedical Co Ltd's wound care division specializes in developing products and solutions that help accelerate wound healing, prevent infections, and reduce the risk of complications. The company offers a wide range of products, including antimicrobial and moist wound dressings, which are used for the treatment of acute and chronic wounds such as burns, abrasions, and diabetic foot ulcers. Surgical Technology: ACRO Biomedical Co Ltd's surgical technology division provides healthcare professionals with a wide range of surgical products for various applications, including neurosurgery, plastic surgery, and general surgery. The innovative products offered by ACRO Biomedical Co Ltd for surgical applications include cutting tools, implants, and instruments for minimally invasive procedures. Products: ACRO Biomedical Co Ltd offers a wide range of products for various applications and medical specialties. Some of the company's key products include: - ACL-Bioimplant: A bioimplant for cruciate ligament repair made from human cartilage and biomaterials. - ACRO-CAF: A bone grafting material for bone transplantation. - ACRO-Mixtop: A wound healing agent for the treatment of burns, abrasions, and chronic wounds. - ACRO-OSTEOT: A surgical bone drill for orthopedics and neurosurgery. - ACRO-BioSIS: A tissue adhesive for surgical applications. Summary: ACRO Biomedical Co Ltd is a leading company in biomedical technology that offers innovative solutions for the preservation and restoration of people's health. With its three main divisions: Regenerative Medicine, Wound Care, and Surgical Technology, the company provides a wide range of products and solutions for medical professionals and patients. The company's products are marketed worldwide and are known for their quality, reliability, and effectiveness. ACRO Biomedical Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding ACRO Biomedical Co's Debt Structure

ACRO Biomedical Co's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing ACRO Biomedical Co's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to ACRO Biomedical Co’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in ACRO Biomedical Co’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about ACRO Biomedical Co stock

What is the debt of ACRO Biomedical Co this year?

ACRO Biomedical Co has a debt level of 0.07 USD this year.

What was the debt of ACRO Biomedical Co compared to the previous year?

The debt of ACRO Biomedical Co has increased by -187.5% compared to the previous year dropped.

What are the consequences of high debt for investors in ACRO Biomedical Co?

High debt can pose a risk for investors of ACRO Biomedical Co, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of ACRO Biomedical Co?

Low debt means that ACRO Biomedical Co has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from ACRO Biomedical Co affect the company?

An increase in debt of ACRO Biomedical Co can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of ACRO Biomedical Co affect the company?

A reduction in debt of ACRO Biomedical Co can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of ACRO Biomedical Co?

Some factors that can influence the debt of ACRO Biomedical Co include investments, acquisitions, operating costs, and revenue development.

Why are the debts of ACRO Biomedical Co so important for investors?

The debts of ACRO Biomedical Co are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can ACRO Biomedical Co take to change the debt?

To change the debt, ACRO Biomedical Co can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does ACRO Biomedical Co pay?

Over the past 12 months, ACRO Biomedical Co paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, ACRO Biomedical Co is expected to pay a dividend of 0 USD.

What is the dividend yield of ACRO Biomedical Co?

The current dividend yield of ACRO Biomedical Co is .

When does ACRO Biomedical Co pay dividends?

ACRO Biomedical Co pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of ACRO Biomedical Co?

ACRO Biomedical Co paid dividends every year for the past 0 years.

What is the dividend of ACRO Biomedical Co?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is ACRO Biomedical Co located?

ACRO Biomedical Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von ACRO Biomedical Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of ACRO Biomedical Co from 7/29/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 7/29/2024.

When did ACRO Biomedical Co pay the last dividend?

The last dividend was paid out on 7/29/2024.

What was the dividend of ACRO Biomedical Co in the year 2023?

In the year 2023, ACRO Biomedical Co distributed 0 USD as dividends.

In which currency does ACRO Biomedical Co pay out the dividend?

The dividends of ACRO Biomedical Co are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von ACRO Biomedical Co

Our stock analysis for ACRO Biomedical Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of ACRO Biomedical Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.